NCT03272477 2024-04-17
TP-II
Palleos Healthcare GmbH
Phase 2 Completed
Clinical Trials
9 trialsNCT02301143 2019-03-20
LAPACT
Celgene
Phase 2 Completed
NCT01142778 2018-03-16
AVATAXHER
Hoffmann-La Roche
Phase 2 Completed
NCT00865189 2017-08-04
INOVA
Hoffmann-La Roche
Phase 2 Completed
NCT01213407 2016-05-19
GBM-Vax
Activartis Biotech
Phase 2 Completed
NCT00849472 2014-03-04
Treatment With Pazopanib for Neoadjuvant Breast Cancer
GlaxoSmithKline
Phase 2 Completed
NCT01574729 2012-06-28
rAd-p53
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 2 Unknown
NCT00191308 2011-10-21
Molecular Profiling in Lung Cancer Patients
Eli Lilly and Company
Phase 2 Completed
NCT00191789 2010-07-27
Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer
Eli Lilly and Company
Phase 2 Completed